Peptide side effects: the most common ones, by peptide and by category
From mild injection-site redness to GLP-1 nausea to potential growth-related concerns, here's a clear breakdown of what to actually expect.
by Editorial team
Universally common (most peptides)
Injection-site redness, mild itching, occasional small bruise — these affect most users at some point and rarely indicate anything serious. Rotating sites and using fresh needles minimizes them.
Mild fatigue or 'flu-like' feeling in the first few doses of a new peptide is common and typically resolves within a week.
GLP-1 family (semaglutide, tirzepatide, retatrutide)
Nausea, constipation, reflux, and fatigue in the first 4–6 weeks. Slow titration cuts these dramatically. Less common: gallbladder issues, pancreatitis (rare but serious).
Long-term: lean mass loss without protein and resistance training. This is the side effect almost nobody talks about.
GH secretagogues (CJC, Ipa, MK-677)
Water retention, hand numbness, hunger increase (especially MK-677), occasional vivid dreams. Usually mild and dose-dependent.
Healing peptides (BPC-157, TB-500)
Unusually clean side effect profile in animal data and observational human use. Theoretical concerns about angiogenesis-driven cancer risk exist but have no clear human evidence either way.